Pangenomic Health Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was CAD 1.06 million compared to CAD 0.821332 million a year ago. Basic loss per share from continuing operations was CAD 0.1 compared to CAD 0.2 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | -25.00% | -70.00% |
27/05 | Pangenomic Health Inc. announced that it has received CAD 1.075116 million in funding | CI |
17/05 | Pangenomic Health Inc. announced that it expects to receive CAD 1 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-70.00% | 1.4M | |
-6.59% | 29.06B | |
+39.31% | 9.19B | |
+36.91% | 4.58B | |
-34.57% | 2.49B | |
-9.44% | 1.6B | |
-24.82% | 1.28B | |
-39.44% | 1.04B | |
+4.74% | 940M | |
-41.98% | 809M |
- Stock Market
- Equities
- NARA Stock
- News Pangenomic Health Inc.
- Pangenomic Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023